Artículos con órdenes de acceso público - Marc SansonMás información
TotalNIHINSERMCancer Research UKANRSCLWellcomeDFGMRCGenome CanadaKWFBrain Tumour Charity, UKDoDNIHREuropean CommissionGovernment of ItalyBlood Cancer UKBMBFAIRC Foundation for Cancer Research in ItalyChildren's Tumor Foundation, USAVAMacArthurNHMRCFNRSHelmholtzSwedish Research CouncilAlzheimers's UKVersus Arthritis, UKBHFWHOMichael J Fox FoundationNCNLeducq Foundation, USAAlex's Lemonade StandAmerican Brain Tumor AssociationHFSPOICR
No disponibles en ningún lugar: 9
Molecular analysis of diffuse intrinsic brainstem gliomas in adults
G Reyes-Botero, M Giry, K Mokhtari, M Labussière, A Idbaih, JY Delattre, ...
Journal of neuro-oncology 116, 405-411, 2014
Órdenes: US National Institutes of Health
Interlaboratory comparison of IDH mutation detection
MJ Van Den Bent, C Hartmann, M Preusser, T Ströbel, HJ Dubbink, ...
Journal of neuro-oncology 112, 173-178, 2013
Órdenes: US National Institutes of Health
Prognostic value of Ki67 index in anaplastic oligodendroglial tumours–a translational study of the European Organization for Research and Treatment of Cancer Brain Tumor Group
M Preusser, R Hoeftberger, A Woehrer, E Gelpi, M Kouwenhoven, ...
Histopathology 60 (6), 885-894, 2012
Órdenes: US National Institutes of Health
Epidermal growth factor receptor extracellular domain mutations in primary glioblastoma
A Idbaih, J Aimard, B Boisselier, Y Marie, S Paris, E Criniere, ...
Neuropathology and applied neurobiology 35 (2), 208-213, 2009
Órdenes: National Institute of Health and Medical Research, France
VEGFA SNP rs2010963 is associated with vascular toxicity in recurrent glioblastomas and longer response to bevacizumab
AL Di Stefano, M Labussiere, G Lombardi, M Eoli, D Bianchessi, ...
Journal of neuro-oncology 121, 499-504, 2015
Órdenes: Government of Italy
Predictive biomarkers investigated in glioblastoma
E Tabouret, O Chinot, M Sanson, A Loundou, K Hoang-Xuan, JY Delattre, ...
Expert review of molecular diagnostics 14 (7), 883-893, 2014
Órdenes: National Institute of Health and Medical Research, France
Integrated proteogenomic characterization of glioblastoma evolution
KH Kim, S Migliozzi, H Koo, JH Hong, SM Park, S Kim, HJ Kwon, S Ha, ...
Cancer Cell 42 (3), 358-377. e8, 2024
Órdenes: National Institute of Health and Medical Research, France
Actionable FGFR1 and BRAF mutations in adult circumscribed gliomas
E Trisolini, DE Wardighi, M Giry, P Bernardi, RL Boldorini, K Mokhtari, ...
Journal of Neuro-Oncology 145, 241-245, 2019
Órdenes: Swiss Cancer League
LZTR1 Mutation Mediates Oncogenesis through Stabilization of EGFR and AXL
A Ko, M Hasanain, YT Oh, F d'Angelo, D Sommer, B Frangaj, S Tran, ...
Cancer Discovery 13 (3), 702-723, 2023
Órdenes: US National Institutes of Health, Children's Tumor Foundation, USA
Disponibles en algún lugar: 109
Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions
PY Wen, M Weller, EQ Lee, BM Alexander, JS Barnholtz-Sloan, ...
Neuro-oncology 22 (8), 1073-1113, 2020
Órdenes: US National Institutes of Health
Genome-wide association study identifies five susceptibility loci for glioma
S Shete, FJ Hosking, LB Robertson, SE Dobbins, M Sanson, B Malmer, ...
Nature genetics 41 (8), 899-904, 2009
Órdenes: US National Institutes of Health, German Research Foundation, Cancer Research UK
Mechanisms and therapeutic implications of hypermutation in gliomas
M Touat, YY Li, AN Boynton, LF Spurr, JB Iorgulescu, CL Bohrson, ...
Nature 580 (7804), 517-523, 2020
Órdenes: US National Institutes of Health, National Institute of Health and Medical …
IDH1 and IDH2 Mutations Are Prognostic but not Predictive for Outcome in Anaplastic Oligodendroglial Tumors: A Report of the European Organization for …
MJ Van den Bent, HJ Dubbink, Y Marie, AA Brandes, MJB Taphoorn, ...
Clinical Cancer Research 16 (5), 1597-1604, 2010
Órdenes: US National Institutes of Health
A new alternative mechanism in glioblastoma vascularization: tubular vasculogenic mimicry
S El Hallani, B Boisselier, F Peglion, A Rousseau, C Colin, A Idbaih, ...
Brain 133 (4), 973-982, 2010
Órdenes: US National Institutes of Health
Glioblastoma targeted therapy: updated approaches from recent biological insights
M Touat, A Idbaih, M Sanson, KL Ligon
Annals of Oncology 28 (7), 1457-1472, 2017
Órdenes: US National Institutes of Health
Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3 …
MJ van den Bent, B Baumert, SC Erridge, MA Vogelbaum, AK Nowak, ...
The Lancet 390 (10103), 1645-1653, 2017
Órdenes: US National Institutes of Health, Cancer Research UK, UK Medical Research …
Genome-wide association study of glioma subtypes identifies specific differences in genetic susceptibility to glioblastoma and non-glioblastoma tumors
BS Melin, JS Barnholtz-Sloan, MR Wrensch, C Johansen, D Il'Yasova, ...
Nature genetics 49 (5), 789-794, 2017
Órdenes: US National Institutes of Health, Genome Canada, German Research Foundation …
MGMT Promoter Methylation Is Prognostic but Not Predictive for Outcome to Adjuvant PCV Chemotherapy in Anaplastic Oligodendroglial Tumors: A Report From …
MJ van den Bent, HJ Dubbink, M Sanson, CR van der Lee-Haarloo, ...
Journal of Clinical Oncology 27 (35), 5881-5886, 2009
Órdenes: US National Institutes of Health
Genome-wide association study of glioma and meta-analysis
P Rajaraman, BS Melin, Z Wang, R McKean-Cowdin, DS Michaud, ...
Human genetics 131, 1877-1888, 2012
Órdenes: US National Institutes of Health
Pathway-based classification of glioblastoma uncovers a mitochondrial subtype with therapeutic vulnerabilities
L Garofano, S Migliozzi, YT Oh, F D’Angelo, RD Najac, A Ko, B Frangaj, ...
Nature Cancer 2 (2), 141-156, 2021
Órdenes: US National Institutes of Health, AIRC Foundation for Cancer Research in Italy
La información de publicación y financiación se determina de forma automática mediante un programa informático